DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,050
-70 (-0.46%)
Apr 2, 2025, 3:30 PM KST

DongKook Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
50,27260,55273,69385,44454,537
Upgrade
Short-Term Investments
40,58233,60829,51283,439120,425
Upgrade
Trading Asset Securities
--3,8991,0471,329
Upgrade
Cash & Short-Term Investments
90,85494,160107,105169,929176,291
Upgrade
Cash Growth
-3.51%-12.09%-36.97%-3.61%13.96%
Upgrade
Accounts Receivable
180,595161,107134,072123,949122,675
Upgrade
Other Receivables
22,00017,77917,36114,04612,745
Upgrade
Receivables
209,389179,061151,600139,299136,983
Upgrade
Inventory
159,577138,343120,152102,59179,048
Upgrade
Prepaid Expenses
4,6394,0582,6293,9491,723
Upgrade
Other Current Assets
5,5473,5753,8364,4574,717
Upgrade
Total Current Assets
470,007419,197385,321420,226398,763
Upgrade
Property, Plant & Equipment
299,459272,705263,355234,941194,967
Upgrade
Long-Term Investments
119,662108,30087,89271,36347,375
Upgrade
Goodwill
12,172----
Upgrade
Other Intangible Assets
19,7338,5378,2026,9167,299
Upgrade
Long-Term Accounts Receivable
-0----
Upgrade
Long-Term Deferred Tax Assets
1,8921,7021,6951,9701,944
Upgrade
Long-Term Deferred Charges
10,5947,6262,672--
Upgrade
Other Long-Term Assets
19,64615,46613,1918,6556,816
Upgrade
Total Assets
953,165839,535768,330750,076663,165
Upgrade
Accounts Payable
80,35162,06933,40529,17126,523
Upgrade
Accrued Expenses
4,2123,6242,7543,6032,087
Upgrade
Short-Term Debt
46,74448,22836,95482,19113,854
Upgrade
Current Portion of Long-Term Debt
2,2275,729---
Upgrade
Current Portion of Leases
3,0892,5281,9542,0442,557
Upgrade
Current Income Taxes Payable
14,0854,94910,2936,75811,891
Upgrade
Current Unearned Revenue
416.120.950.860.780.84
Upgrade
Other Current Liabilities
81,56875,98288,15396,50188,053
Upgrade
Total Current Liabilities
232,692203,111173,514220,269144,966
Upgrade
Long-Term Debt
22,90418,75025,00010,00049,000
Upgrade
Long-Term Leases
5,7231,4692,4493,6873,115
Upgrade
Long-Term Deferred Tax Liabilities
6,5054,8464,8065,7653,288
Upgrade
Other Long-Term Liabilities
6,3647,1446,4716,3786,607
Upgrade
Total Liabilities
274,189235,319212,241246,099207,431
Upgrade
Common Stock
22,23022,23022,23022,23022,230
Upgrade
Additional Paid-In Capital
24,80016,94414,37114,45914,293
Upgrade
Retained Earnings
558,208507,318467,179419,761376,729
Upgrade
Treasury Stock
-3,016-3,053-3,095-3,138-3,138
Upgrade
Comprehensive Income & Other
869.51869.51869.51869.51869.51
Upgrade
Total Common Equity
603,092544,309501,554454,181410,983
Upgrade
Minority Interest
75,49931,48029,12527,07924,438
Upgrade
Shareholders' Equity
678,976604,216556,089503,977455,734
Upgrade
Total Liabilities & Equity
953,165839,535768,330750,076663,165
Upgrade
Total Debt
80,68776,70466,35797,92268,526
Upgrade
Net Cash (Debt)
10,16717,45640,74872,008107,765
Upgrade
Net Cash Growth
-41.76%-57.16%-43.41%-33.18%14.14%
Upgrade
Net Cash Per Share
227.26390.25911.091610.232409.84
Upgrade
Filing Date Shares Outstanding
43.9743.9643.9643.9543.95
Upgrade
Total Common Shares Outstanding
43.9743.9643.9643.9543.95
Upgrade
Working Capital
237,315216,087211,807199,957253,796
Upgrade
Book Value Per Share
13716.5112381.2611410.5510334.439351.51
Upgrade
Tangible Book Value
571,187535,772493,352447,265403,684
Upgrade
Tangible Book Value Per Share
12990.8712187.0711223.9510177.079185.42
Upgrade
Land
114,638102,959107,23491,41582,086
Upgrade
Buildings
132,740114,32382,85556,32552,435
Upgrade
Machinery
239,876211,538172,505158,211138,956
Upgrade
Construction In Progress
9,2577,53546,09157,78536,871
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.